Searched for
PHARMEASY DRHP
Online edtech platform Physics Wallah appoints Ajinkya Jain as Group General CounselPhysics Wallah Ltd has appointed Ajinkya Jain as the Group General Counsel, Company Secretary, and Compliance Officer. Jain brings extensiv...- Kalpataru files DRHP for Rs 1,600 crore IPO. Check detailsKalpataru submitted its DRHP to SEBI to raise Rs 1,590 crore through an IPO. The proceeds will address outstanding borrowings and corporate...
- Byju’s lenders scrap talks to recast $1.2B loan; Janus Henderson cuts PharmEasy valuation furtherByju’s woes seem to have no end. The company has suffered a series of setbacks over the last year, including ED raids and valuation markdow...
- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
- PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
- PharmEasy pulls out market listing planThe company will consider raising funds via rights issue, reported CNBC. API Holdings rights issue will have Compulsory Convertible Prefere...
- IPOs on hold as startups look to wait out stormWhat is significant is that the country’s markets regulator Securities and Exchange Board of India (Sebi) has not given a nod to most of th...
- FirstCry plans $1 billion IPO, may seek Sebi nod next monthFirstCry turned profitable in fiscal year 2021, as per recent regulatory filings, clocking a net profit of nearly Rs 216 crore compared wit...
- Indian startup IPOs continue to be delayed amid geopolitical headwindsIn an exclusive chat, which was a part of the Economic Times Startup Awards 2021, in Bengaluru on Macrh 12, Sahil Barua, cofounder, and chi...
- Watch out for these factors in Thyrocare as closely as you would watch any symptoms!Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...
- PharmEasy parent API Holdings gets Sebi nod for Rs 6,250 cr-IPOThe company will use Rs 1,929 crore from the IPO proceeds to repay or prepay borrowings and Rs 1,259 crore to fund organic growth initiativ...
- Oyo may reduce IPO size, valuation may be readjusted tooThe IPO issue size is expected to be much lower than $1 billion, these people said, while in its draft IPO papers with the markets regulato...
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
- PharmEasy parent API Holdings files draft papers for Rs 6,250 crore IPOAPI Holdings intends to utilise the net proceeds for prepayment or repayment of all or a portion of certain outstanding borrowings availed ...
- PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
- ETtech Deals Digest: PharmEasy, Cred raise funds this weekOnline pharmacy PharmEasy and credit card repayment platform Cred were among the startups that raised funds this week with a significant bu...
- Trifecta Capital invests Rs 400 crore in four Indian tech companiesThe fund has invested in ixigo, Good Glamm Group (MyGlamm), API Holdings (PharmEasy), and Meesho, in line with its strategy to back growth ...
- PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
- PharmEasy plans to file IPO papers by OctoberPharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation ...
Load More
